Drug Profile
Pegfilgrastim biosimilar - Chong Kun Dang
Alternative Names: CKD-12101; Neulasta® biosimilarLatest Information Update: 25 Nov 2021
Price :
$50
*
At a glance
- Originator Chong Kun Dang
- Class Antineoplastics; Chemoprotectants; Granulocyte colony-stimulating factors; Polyethylene glycols; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neutropenia